wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36070362-3B01B730-7C2F-43F7-87A7-9EF7A880FB3E
Q36070362-3B01B730-7C2F-43F7-87A7-9EF7A880FB3E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36070362-3B01B730-7C2F-43F7-87A7-9EF7A880FB3E
Sample size calculations for clinical trials targeting tauopathies: a new potential disease target
P2860
Q36070362-3B01B730-7C2F-43F7-87A7-9EF7A880FB3E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36070362-3B01B730-7C2F-43F7-87A7-9EF7A880FB3E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e889f0d40f89705ea495dfa2fa7b0d6de3f9034e
P2860
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy.